Pharmafile Logo

Patient Centricity: Turning Rhetoric into Reality

Live webinar: Thursday 30th March 10:00 EDT / 15:00 BST / 16:00 CEST


As patients become increasingly involved in their own health and healthcare systems demand more evidence of outcomes, pharmaceutical organisations have been moving towards a business model that puts patients at the heart of everything they do.

However is this transformation working? A patient-centric model demands huge investment and a company-wide commitment to putting patient wants and needs first during all stages of healthcare delivery, from drug discovery through to long-term disease management.

Join market research consultants Claire Richardson and Mariel Metcalfe for this complimentary webinar in which they discuss the value of patient centricity, where the industry is now and whether market research can better support the drive towards achieving it. You will hear insights and experiences from pharmaceutical organisations regarding their current practices – including examples of where patient understanding has positively impacted brands as well as where it is falling short. Claire and Mariel will look at the challenges pharma faces and investigate what market research can do to help overcome them. Finally, they will investigate the impact pharma’s patient-centric model is likely to have on the people it’s meant to affect – patients – as well as physicians trying to treat them.

Register now: http://bit.ly/2lBodvj

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Research Partnership has published a new Living with Ulcerative Colitis (UC) market report for 2016

Ulcerative Colitis (UC) is a progressive and debilitating disease which affects between 2.5 to 3 million people in Europe. Living with UC is a quantitative study conducted online amongst 325 patients, including...

The Internet of Things

Evolution from man to machine

Therapy Watch expands its oncology portfolio

This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio...

Time for a new language for asthma?

Despite the global advances made in the treatment for asthma, many studies have shown that asthma remains uncontrolled for a large proportion of patients, when assessed according to international guidelines....

Evaluating the impact of your medical congress presence…more cost effectively

Organising a company’s presence, not just logistically, but in terms of delivering key information, data and messages, is a massive part of some people’s workload at this time of year....

Delivering multi-stakeholder patient journey insights in oncology with creative outputs and data visualisation

Two clients were co-developing a product and needed to understand the patient journey in two areas of oncology, in order to identify the leverage points where they could provide an...

Webinar: Understanding Patient Willingness to Pay

What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets?

Research Partnership welcomes 22 new Graduates

As part of our continued growth, we are delighted to announce a new intake of 17 Research Analysts and 5 Fieldwork Project Coordinators into our annual market research graduate programme.http://www.researchpartnership.com/news/2016/09/new-graduates-2016/

Case study: Tracking a product launch in a dynamic and competitive market

With the imminent expected approval and launch of a new product, our client needed to conduct global tracking research to understand knowledge, perceptions, awareness and recall around their product and the quality...

Understanding the Chronic Disease Patient Journey in Emerging Markets

The benefits of understanding the patient journey are well documented in mature markets. But in emerging markets the patient journey is less understood. We recently presented a webinar hosted by...